// App-Quantinova.ai

4408 : Mutant ABL1 is a genetic dependency in non-small cell lung cancer amenable to pharmacological intervention

Researchers

Presenter

  • PEDRO Torres-Ayuso

Principal Investigators

  • Ewelina Testoni

  • Natalie L. Stephenson

  • Anna A. Marusiak

  • Eleanor W. Trotter

  • Andrew Hudson

  • Cassandra L. Hodgkinson

  • Christopher J. Morrow

  • Caroline Dive

  • John Brognard

Medical Centers

  • Cancer Research UK Manchester Institute, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

Drug/Treatment

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved